Our Services

→ Specialized consultancy services supporting drug discovery and development projects at any stage.

→ Facilitation of collaborations and partnerships with both academic institutions and industrial entities for integrated drug discovery programs.

→ Assistance in grant proposal writing, strategic project planning, and regulatory guidance for early-stage pharmaceutical projects.

→ Utilization of advanced analytical techniques such as Nuclear Magnetic Resonance (NMR), High-Resolution Mass Spectrometry (HRMS), and High-Performance Liquid Chromatography (HPLC) for structural and purity assessment.

→ Structural elucidation and detailed physicochemical property profiling of compounds.

→ High-standard quality control ensuring integrity and accuracy in data reporting.

→ Comprehensive development of robust biochemical and cell-based assays for evaluating therapeutic efficacy and potency.

→ Enzyme inhibition assays tailored to assess compound specificity and activity.

→ Validation protocols designed to meet international regulatory standards, ensuring reproducibility and accuracy of assay results.

→ Development of novel assays for new and challenging therapeutic targets.

→ Custom-designed synthesis routes tailored to meet specific client requirements.

→ Efficient multi-step organic synthesis, including complex molecule synthesis and lead optimization.

→ Expertise in scalable synthetic methodologies, route optimization, and process development suitable for preclinical and early clinical phases.

→ Full analytical characterization of synthesized compounds to ensure purity and consistency.

→ Advanced molecular docking for precise ligand-target interactions.

→ Pharmacophore modeling to identify key molecular features essential for biological activity.

→ Molecular dynamics simulations providing insights into molecular stability and behavior over time.

→ Quantitative Structure-Activity Relationship (QSAR) modeling to predict biological activity of novel compounds.

→ Expertise in both ligand-based and structure-based approaches to efficiently design potent therapeutic candidates.